Benefits of VCE-003.2, a cannabigerol quinone derivative, against inflammation-driven neuronal deterioration in experimental Parkinson's disease: possible involvement of different binding sites at the PPARγ receptor.
about
Benefits of VCE-003.2, a cannabigerol quinone derivative, against inflammation-driven neuronal deterioration in experimental Parkinson's disease: possible involvement of different binding sites at the PPARγ receptor.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Benefits of VCE-003.2, a canna ...... g sites at the PPARγ receptor.
@en
Benefits of VCE-003.2, a canna ...... g sites at the PPARγ receptor.
@nl
type
label
Benefits of VCE-003.2, a canna ...... g sites at the PPARγ receptor.
@en
Benefits of VCE-003.2, a canna ...... g sites at the PPARγ receptor.
@nl
prefLabel
Benefits of VCE-003.2, a canna ...... g sites at the PPARγ receptor.
@en
Benefits of VCE-003.2, a canna ...... g sites at the PPARγ receptor.
@nl
P2093
P2860
P50
P1476
Benefits of VCE-003.2, a canna ...... g sites at the PPARγ receptor.
@en
P2093
Belén Palomares
Carolina Pavicic
Cristina Palomo-Garo
Javier Fernández-Ruiz
Joel Ferrer-Hernández
M Luz Bellido
M Ruth Pazos
María Gómez-Cañas
Sara Campo
Sonia Burgaz
P2860
P2888
P356
10.1186/S12974-018-1060-5
P577
2018-01-16T00:00:00Z
P6179
1100433810